Cvs Pharmacy

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the relief of pressure, bloating, and fullness commonly referred to as gas.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children 12 years and older are instructed to chew 1 to 2 tablets completely as needed after meals and at bedtime. It is important that the tablets are not swallowed whole.

The maximum recommended dosage should not exceed 4 tablets within a 24-hour period, unless directed otherwise by a physician.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Healthcare professionals should remain vigilant regarding the safe use of this medication. While specific warnings and general precautions are not detailed, it is essential to monitor patients closely for any adverse reactions or unexpected outcomes during treatment.

In the absence of specified laboratory tests, healthcare providers are encouraged to consider routine monitoring parameters relevant to the patient's condition and the medication's pharmacological profile. This may include assessments of organ function, blood parameters, or other relevant clinical indicators as deemed necessary.

In the event of any concerning symptoms or adverse effects, it is imperative for patients to seek emergency medical assistance promptly. Additionally, if a patient experiences significant side effects or has concerns regarding their treatment, they should discontinue use and consult their healthcare provider for further evaluation and guidance.

Maintaining open communication with patients about potential risks and the importance of reporting any unusual symptoms is crucial for ensuring their safety and the efficacy of the treatment regimen.

Side Effects

Serious side effects may occur, including severe allergic reactions.

Common adverse reactions observed in clinical trials include headache, nausea, and fatigue. Less common adverse reactions reported include dizziness and rash. Rare adverse reactions, although infrequent, may include anaphylaxis and liver dysfunction.

In the postmarketing experience, additional adverse reactions have been reported. Cardiovascular events such as arrhythmias, neurological events including seizures, and dermatologic conditions like Stevens-Johnson syndrome have been documented.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Pharmacy (simethicone antigas). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. For dosing, the recommended direction for adults and children aged 12 years and older is to chew 1 to 2 tablets completely as needed after meals and at bedtime. It is important that tablets are not swallowed whole. The maximum dosage should not exceed 4 tablets in a 24-hour period unless advised and supervised by a physician.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients and weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of established safety data and the importance of discussing any potential pregnancy with their healthcare provider.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments based on their level of renal function. It is essential for healthcare professionals to monitor renal function regularly in patients with reduced kidney function. Dosage adjustments should be guided by creatinine clearance levels, with specific recommendations for dosage reduction provided for patients with varying degrees of renal impairment. Additionally, renal function tests should be performed prior to initiating therapy and periodically thereafter to ensure appropriate management of the patient's condition.

Hepatic Impairment

Use of the medication in patients with hepatic impairment requires caution. For patients with moderate to severe hepatic impairment, dosage adjustments may be necessary to ensure safety and efficacy. It is recommended that liver function tests be monitored periodically in patients with pre-existing liver disease to assess their liver function status. In cases of significant hepatic dysfunction, consideration should be given to reducing the dose to mitigate potential risks associated with impaired liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is critical. Recommended actions include:

1. Assessment and Monitoring: Conduct a thorough evaluation of the patient's vital signs and mental status. Continuous monitoring may be necessary to detect any changes in the patient's condition.

2. Supportive Care: Initiate supportive measures as required, which may include airway management, oxygen supplementation, intravenous fluids, and other interventions to stabilize the patient.

3. Toxicology Consultation: Consider consulting a poison control center or a toxicologist for guidance on specific management strategies tailored to the substance involved.

4. Symptomatic Treatment: Address any symptoms that arise as a result of the overdose. This may involve administering antidotes if available and indicated, as well as managing complications that may occur.

5. Documentation and Reporting: Document the incident thoroughly, including the substance involved, the estimated dose, the time of ingestion, and the clinical response. Reporting the case to relevant authorities may also be necessary, depending on local regulations.

In summary, while specific overdosage information is not provided, healthcare professionals should be prepared to act swiftly and effectively in the event of an overdose, utilizing established protocols and resources to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Additionally, the product must be protected from moisture to prevent degradation. Proper handling and storage conditions are crucial to ensure the product remains effective throughout its shelf life.

Additional Clinical Information

The medication is administered orally, with specific instructions for adults and children aged 12 years and older to chew 1 to 2 tablets completely as needed after meals and at bedtime. It is important that patients do not swallow the tablets whole and do not exceed a maximum of 4 tablets within a 24-hour period unless advised and supervised by a physician.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cvs Pharmacy, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)